Breaking the 'Undruggable' Barrier: Nanoparticle-Based Combination Therapy Utilizing Sotorasib and PD-L1 Inhibitor for Treating Non-Small Cell Lung Cancer Patients with KRASG12C Mutations
BIO Web Conf., 174 (2025) 02009
DOI: https://doi.org/10.1051/bioconf/202517402009